EMJ GOLD

Filter Advertise With Us

Month in pharma news, explained

Month in pharma news, explained – April 2026

Here is your April 2026 pharma news roundup. It’s time to reflect on a big month for weight loss drugs and more.

Exterior of glass AWS office building

Amazon launches AI platform for faster drug discovery

Amazon Web Services has launched a new AI platform to help drug developers identify and test potential candidates.

Novo partners with OpenAI to boost drug development

Novo Nordisk announced on 14 April 2026 a strategic partnership with OpenAI to boost drug development by streamlining manufacturing, supply chains and distribution.

Man talking to healthcare professional

£6.3m fund targets men’s health gap in England

A new fund has launched to tackle widening health inequalities among underserved men in England.

Biopharma company joins lawsuit over CMS hemp pilot

MMJ International Holdings has joined plaintiffs taking legal action against the CMS.

Novo Nordisk launches higher-dose semaglutide

Novo Nordisk has launched a 7.2 mg semaglutide injection in the US, following FDA approval on 19 March.

ASCVD costs global health industry $680bn annually

Atherosclerotic cardiovascular disease costs the equivalent of Sweden’s entire economy, a new report has revealed.

Robot arm holding a cartoon heart

World Health Day: VML's top 10 healthcare trends

Healthcare is moving into a new phase in which trust, not just treatment, will shape success, says VML Health.

Eli Lilly office building

Lilly’s weight loss pill wins FDA approval

Eli Lilly won FDA approval on 1 April 2026 for a once-daily oral GLP-1, orforglipron.

Loading posts...

« Previous 1 2 3 4 5 … 49 Next »